A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Name: A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
License: Public Domain

Glaxo Wellcome

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anti-hiv-agents combination drug-resistance drug-therapy genotype hiv-1 hiv-infections microbial

hiv infections, hiv-1, drug therapy, combination, zidovudine, drug resistance, microbial, hiv protease inhibitors, lamivudine, indinavir, genotype, phenotype, reverse transcriptase inhibitors, anti-hiv agents

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 830998
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.